Oxyplex 50 mg is an oral oxymetholone product manufactured by Axiolabs and supplied as 50 mg tablets in a 50-tablet package.
Oxyplex 50 mg contains oxymetholone, a synthetic 17-alpha-alkylated anabolic-androgenic steroid derived from testosterone. Oxymetholone is one of the most potent oral anabolic agents, historically developed for medical use in treating anemias caused by deficient red cell production and for stimulating weight gain in catabolic states. Its 17-alpha-alkylation allows for oral bioavailability but also places the compound in a class associated with hepatic considerations.
In clinical medicine, oxymetholone has been approved by the FDA for the treatment of specific anemias, including acquired aplastic anemia and anemias associated with myelofibrosis or myelotoxic drug administration. It has also been studied in HIV-associated wasting and other catabolic conditions. These medical applications are distinct from non-medical bodybuilding use, where oxymetholone is commonly referenced during mass-building or bulking phases due to its reputation for rapid weight and strength gains.
Oxymetholone exerts its effects through binding to androgen receptors, promoting protein synthesis and nitrogen retention. It is notable for producing significant increases in lean body mass and decreases in fat mass in clinical studies, even at moderate doses. However, it is also associated with substantial water retention, which contributes to its reputation for rapid weight gain in non-medical contexts. Non-medical use of oxymetholone falls outside approved medical indications and carries risks that increase with dose and duration.
Oxymetholone is a 17-alpha-alkylated oral anabolic steroid known for potent anabolic activity and significant water retention, with a distinctive profile among oral agents.
Oxymetholone is structurally distinct from most anabolic steroids, featuring a 2-hydroxymethylene group that contributes to its potent anabolic activity despite relatively low binding affinity for the androgen receptor. Its 17-alpha-alkylation enables oral administration but also makes it a substrate for hepatic processing, placing it in the class associated with 17-alpha-alkylated oral steroids and their known hepatic considerations.
The compound does not aromatize to estrogen to a significant degree, yet it is frequently associated with water retention and bloating in non-medical discussions. This effect is attributed to its intrinsic mineralocorticoid-like activity rather than aromatization. Clinical research has demonstrated that oxymetholone at 50 mg/day and 100 mg/day for 12 weeks produced significant increases in total lean body mass (+3.3 kg and +4.2 kg, respectively) and reductions in trunk fat, alongside meaningful gains in maximal voluntary strength.
These characteristics make oxymetholone a compound referenced for aggressive mass-building phases, though its safety profile requires careful consideration given the associated hepatic and lipid effects.
Oxymetholone is one of the most anabolically potent oral steroids, but its practical profile is defined by significant water retention and hepatic considerations. These properties distinguish it from milder orals like oxandrolone.
Axiolabs produces several oral anabolic products that occupy different positions on the potency and tolerability spectrum. Oxyplex 50 mg is an oxymetholone product, which places it among the more potent oral options compared to compounds like Oxandroplex (oxandrolone) and Turanaplex (turinalbol).
For bodybuilders considering injectable alternatives for mass-building, Testaplex C 250 and Decaplex 250 are commonly referenced. The choice between oxymetholone and other compounds depends on goals, experience level, and individual tolerances, particularly regarding hepatic and cardiovascular markers.
The information below is provided for educational reference only. Oxymetholone is a prescription medication; medical use requires appropriate diagnosis and clinical supervision. Non-medical use falls outside approved indications.
In non-medical bodybuilding contexts, oxymetholone is commonly referenced in the range of 50–100 mg per day for men, typically split into two or three doses due to its relatively short half-life. Some experienced users report higher totals, but the 50–100 mg/day range represents the most frequently discussed window. Women are generally cautioned against oxymetholone due to high virilization risk.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Bodybuilding (men, non-medical) | 50–100 mg / day | Split into 2–3 doses |
| Medical (anemia, supervised) | 1–2 mg/kg / day typical | Individualized by clinician |
| Stacking with injectables | Typically lower end of range | Per cycle protocol |
Oxymetholone is frequently referenced as a kickstart compound in injectable-based mass-building cycles rather than as a standalone cycle. In non-medical contexts, it is sometimes combined with compounds such as Testaplex E 250 or Decaplex 250 during the initial weeks of a bulking protocol. Cycle duration in non-medical discussions is commonly limited to 4–6 weeks due to the hepatic considerations associated with 17-alpha-alkylated compounds.
Because oxymetholone does not aromatize significantly, aromatase inhibitors are not typically referenced for managing estrogenic effects from this compound alone. However, its potent water retention may require management in some contexts. Blood pressure and lipid monitoring are frequently discussed due to the compound's known effects on HDL cholesterol and potential for fluid retention.
Liver support supplementation is commonly referenced during oral anabolic use, though evidence for specific protocols remains limited. Bloodwork monitoring for hepatic markers is particularly relevant given oxymetholone's 17-alpha-alkylated structure.
Oxymetholone suppresses endogenous testosterone production, and post-cycle therapy is commonly recommended after a cycle. Agents such as Clomiplex and Tamoxiplex are frequently referenced for this purpose. PCT protocols vary based on cycle length, compounds used, and individual factors.
Dosing strategies and support protocols should account for individual experience and health status. The information above is for educational reference and does not constitute medical advice.
Oxymetholone is a potent anabolic steroid with significant hepatic and cardiovascular considerations. Medical use requires appropriate diagnosis and ongoing clinical supervision.
Oxymetholone carries boxed warnings for peliosis hepatitis, liver cell tumors, and blood lipid changes that may increase cardiovascular risk. Peliosis hepatitis involves blood-filled cysts in the liver that can be present with minimal dysfunction but may lead to life-threatening liver failure or intra-abdominal hemorrhage. Liver cell tumors, while often benign and androgen-dependent, can be malignant and may not regress upon discontinuation.
Blood lipid changes associated with oxymetholone include decreased high-density lipoprotein and sometimes increased low-density lipoprotein, potentially having a serious impact on atherosclerosis and coronary artery disease risk.
Oxymetholone is not approved for bodybuilding or athletic performance enhancement. Non-medical use falls outside approved indications and may carry additional health risks beyond those associated with supervised medical use. Product potency verification does not establish that non-medical use is safe or appropriate.
Hepatic effects are a primary concern. Cholestatic jaundice is the most important hepatic side effect, with peliosis hepatis and hepatic tumors being less common but serious risks. Liver function tests should be monitored periodically during medical use.
Androgenic effects can include acne, hirsutism, hair loss, and voice changes. In women, virilization including clitoral enlargement and voice deepening may be irreversible. Menstrual irregularities may occur.
Oxymetholone can suppress endogenous testosterone production and reduce sperm production. Cardiovascular effects may include lipid profile alterations and fluid retention. Hemoglobin and hematocrit should be monitored for polycythemia with high-dose use.
Other reported effects include nausea, vomiting, and changes in libido.
Oxymetholone is contraindicated in pregnancy (FDA category X) and in patients with known or suspected prostate or male breast cancer. It should be used with caution in patients with pre-existing cardiac, renal, or hepatic disease. Medical evaluation is required before any consideration of therapeutic use, including assessment of hepatic function, lipid profile, and hematologic parameters.
Medically supervised oxymetholone therapy typically involves periodic liver function testing, lipid monitoring, hemoglobin and hematocrit assessment, and in pediatric patients, bone age x-rays every six months. These monitoring practices are relevant to medical use; non-medical use lacks the same clinical oversight.
Store tablets in a cool, dry place away from direct light and moisture. Keep in original packaging until use. Keep out of reach of children. Do not use if the product appears damaged or compromised.
Oxyplex 50 mg is shipped in original manufacturer packaging with discreet, privacy-focused handling.
Outer packaging remains discreet with no external product details. Products are supplied in original manufacturer presentation.
To verify product authenticity, examine the packaging for manufacturer security features and compare against official Axiolabs presentation. Original packaging and consistent labeling help confirm product legitimacy.
For complete delivery details, please see our Shipping Info page.
Proper storage conditions help preserve product integrity and tablet stability.
Store in a cool, dry place at controlled room temperature. Protect from excessive heat, moisture, and direct light. Keep tablets in their original packaging until use. Do not use if the product appears compromised or if tablets show signs of deterioration.
Keep out of reach of children. Follow proper handling practices.
Answers to common questions about Oxyplex 50 mg, oxymetholone, dosing, and product characteristics.
Oxyplex 50 mg contains oxymetholone, an oral anabolic steroid. In medical practice, it is approved for treating specific anemias and for weight gain in catabolic states. In non-medical bodybuilding contexts, it is commonly referenced during mass-building or bulking phases for rapid weight and strength gains. Non-medical use falls outside approved indications.
In bodybuilding contexts, oxymetholone is typically referenced as being taken in 2–3 divided doses per day due to its relatively short half-life. This is distinct from medically supervised dosing, which is individualized by a clinician based on the condition being treated.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after an oxymetholone cycle to support recovery of endogenous testosterone production. Agents such as Clomiplex or Tamoxiplex are commonly referenced for this purpose.
Oxymetholone binds to androgen receptors and strongly activates androgen receptor-mediated signaling, stimulating protein synthesis and erythropoietin production. It is a 17-alpha-alkylated oral steroid that does not aromatize significantly. Clinical studies show it increases lean body mass and reduces fat mass at doses of 50–100 mg/day.
In clinical studies, significant changes in lean body mass and strength were observed after 12 weeks of treatment at 50–100 mg/day. In non-medical bodybuilding discussions, users sometimes report rapid weight gain within the first few weeks, partly attributable to water retention. Individual response varies considerably.
There is no universally "best" oral steroid for bulking. Oxymetholone is among the most potent oral anabolics and is commonly referenced for aggressive mass-building, but its hepatic and cardiovascular considerations are significant. Other compounds such as Methanoplex are also referenced for bulking with different risk profiles. The appropriate choice depends on individual goals and tolerances.
Both are oral 17-alpha-alkylated anabolic steroids, but they have markedly different profiles. Oxymetholone is a potent mass-building compound with significant water retention, while oxandrolone is generally described as milder with minimal water retention, making it more commonly referenced for cutting phases. Axiolabs offers Oxandroplex as its oxandrolone product.
Both are potent oral mass-building steroids, but oxymetholone is generally considered more anabolically potent with greater water retention. Methandienone (Dianabol) is also referenced for bulking but has a different safety profile. Axiolabs offers Methanoplex as its methandienone product.
In clinical research, 100 mg/day of oxymetholone produced significant increases in lean body mass and strength over 12 weeks, but also led to elevated liver transaminases and significant reductions in HDL cholesterol. In non-medical bodybuilding contexts, 100 mg/day represents the higher end of commonly referenced ranges. Oxandroplex 50 mg contains 50 mg per tablet, so 100 mg would equal two tablets daily.
Oxyplex 50 mg is supplied as 50 mg oxymetholone tablets in a 50-tablet package, giving 2,500 mg of total labeled oxymetholone content.
Oxymetholone carries a high risk of virilization in women, including voice deepening, hirsutism, and clitoral enlargement, some of which may be irreversible. It is generally not referenced for women in bodybuilding contexts due to this risk profile. Women considering any anabolic steroid use should be aware of these potential effects.
Oxymetholone is a 17-alpha-alkylated anabolic steroid and carries boxed warnings for peliosis hepatitis and liver cell tumors. Cholestatic jaundice is the most important hepatic side effect. In a 12-week clinical study, elevated liver transaminases were observed at 100 mg/day but not at 50 mg/day. Liver function monitoring is part of medically supervised use.